Class 1. Pulmonary Hypertension Associated with Congenital Cardiovascular Disease

A Rare Case of Familial Methemoglobinemia with Congenital Heart Disease

Jhasaketan Nayak, Karthik Kumar, Sashi Kant Singh, Gaurav Dhingra, Uttam Kumar NathAll India Institute of Medical Sciences.India Oman Medical JournalOman Med J 2024; 39:DOI: 10.5001/omj.2024.16 AbstractMethemoglobinemia is a rare dyshemoglobin disorder which can either be congenital or acquired. Dyshemoglobin disorders can be asymptomatic or symptomatic. We narrate the case of a 12-year-old girl who presented with […]

A Rare Case of Familial Methemoglobinemia with Congenital Heart Disease Read More »

Novel Staged Device Occlusion of Portosystemic Shunt With Atrial Flow Regulator in IVC Stent Platform

Seán T. Kelleher, Kevin P. Walsh, Damien Kenny, Emer Fitzpatrick, Elchanan Bruckheimer, S. Murthy Chennapragada, Pradeep Govender, Philip A. RobertsChildren’s Health Ireland at Crumlin. Schneider Children’s Medical Centre of Israel. Children’s Hospital at Westmead. Tallaght University Hospital.Ireland, Israel and Australia Journal of the American Colege of Cardiology Case ReportsJACC Case Rep 2024; 29: DOI: 10.1016/j.jaccas.2024.102340 AbstractWe

Novel Staged Device Occlusion of Portosystemic Shunt With Atrial Flow Regulator in IVC Stent Platform Read More »

Patent ductus arteriosus (also non-hemodynamically significant) correlates with poor outcomes in very low birth weight infants. A multicenter cohort study

Elena Chesi Dio, Katia Rossi, Giorgia Di Fazzio, GinaAncora, Silvia Galletti, Cecilia Baraldi, MaraCorradi, GiovannaMescoli Agostina Solinas, LucaBraglia, Antonella Di Caprio, Irene Papa, Francesco Di, Riccardo Cuoghi Costantini, Francesca Miselli, Alberto Berardi, Giancarlo GarganoIRCCS di Reggio Emilia. University Hospital of Modena. Infermi Hospital. University of Parma. ARNAS Garibaldi Hospital. University Hospital Sant’Orsola-Malpighi. Maggiore University Hospital.

Patent ductus arteriosus (also non-hemodynamically significant) correlates with poor outcomes in very low birth weight infants. A multicenter cohort study Read More »

Dealing With a Nightmare: A Case Report of Successful Percutaneous Treatment of an Embolized Occluder Device Complicating a Minimal-Fluoroscopy Patent Ductus Arteriosus Closure

Fransiska A. Sihotang, Valerinna PutriUniversitas Brawijaya, Saiful Anwar General Hospital.Indonesia CureusCureus 2024; DOI: 10.7759/cureus.61926 AbstractPatent ductus arteriosus (PDA) is one of the most prevalent acyanotic congenital heart diseases. Percutaneous closure of PDA has been the preferred treatment recommended by the guidelines due to relatively low complications and rapid patient recovery. However, device emboli remain the most

Dealing With a Nightmare: A Case Report of Successful Percutaneous Treatment of an Embolized Occluder Device Complicating a Minimal-Fluoroscopy Patent Ductus Arteriosus Closure Read More »

Feasibility of Treat and Repair Strategy in Congenital Heart Defects With Pulmonary Arterial Hypertension

Satoshi Akagi, Shingo Kasahara, Teiji Akagi, Kentaro Ejiri, Toshiharu Mitsuhashi, Koji Nakagawa, Kazufumi Nakamura, Hiroshi ItoOkayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences. Johns Hopkins Bloomberg School of Public Health. Okayama University Hospital.Japan and United States Journal of the American College of Cardiology AdvancesJACC Adv 2024; 3:DOI: 10.1016/j.jacadv.2024.100887 AbstractBackground: A treatment strategy for congenital heart defects

Feasibility of Treat and Repair Strategy in Congenital Heart Defects With Pulmonary Arterial Hypertension Read More »

Timely PAH Identification in Adults With Repaired Congenital Heart Disease? The ACHD-QuERI Registry Insights

Michael J. Landzberg, Curt J. Daniels, Paul Forfia, Vallerie V. McLaughlin, Karimah S. Bell Lynum, Mona Selej, Alexander R. OpotowskyHarvard Medical School, Brigham and Women’s Hospital and Boston Children’s Hospital. Ohio State University College of Medicine and Nationwide Children’s Hospital. Temple University Hospital. University of Michigan Medical Center. Actelion Pharmaceuticals US, Inc. Cincinnati Children’s Hospital

Timely PAH Identification in Adults With Repaired Congenital Heart Disease? The ACHD-QuERI Registry Insights Read More »

Survival and Risk Factors for Mortality in Infants With Congenital Heart Disease in South Korea

Jue Seong Lee, Jehe Kwon, Hannah Cho, Ju Sun Heo, Kee Soo Ha, Gi Young Jang, O Kyu Noh, Jun Eun ParkKorea University Medical Center and Korea University College of Medicine. University of Oxford. Ajou University School of Medicine. Republic of Korea In VivoIn Vivo 2024; 38: 1984-1992DOI: 10.21873/invivo.13655 AbstractBackground/aim: The survival of patients with congenital heart

Survival and Risk Factors for Mortality in Infants With Congenital Heart Disease in South Korea Read More »

Raghib Syndrome and Pulmonary Arterial Hypertension in a Pediatric Patient: Case Report and Literature Review

Liliana Gozar, Maria Oana Săsăran, Marius Cătălin Cosma, Daniela Toma, Andreea Georgiana Nan, Horea Gozar“George Emil Palade” University of Medicine, Pharmacy, Sciences and Technology. Emergency Institute for Cardiovascular Diseases and Transplantation. Clinical County Hospital Mureș. Romania Journal of Clinical MedicineJ Clin Med 2024; 13: DOI: 10.3390/jcm13123623 AbstractBackground: Raghib syndrome is a rare malformation complex consisting of the

Raghib Syndrome and Pulmonary Arterial Hypertension in a Pediatric Patient: Case Report and Literature Review Read More »

Identifying Key Biomarkers in Pediatric Pulmonary Hypertension: An Investigative Approach

Farida Mindubayeva, Lyudmila Akhmaltdinova, Mariya Ospanova, Bibigul Tukbekova, Zhanat Bolatbekuly, Yuliya Niyazova, Yelena Salikhova, Olga Avdienko, Meruert AkhmetovaKaraganda Medical University. Multiprofile Hospital No. 2 of Karaganda.Kazakhstan ChildrenChildren 2024; DOI: 10.3390/children11060737 AbstractThis study assesses the utility of early biomarkers-5-hydroxyindoleacetic acid (5-HIAA) and insulin-like growth factor 1 (IGF-1)-for diagnosing and monitoring pulmonary hypertension (PH) in children with congenital

Identifying Key Biomarkers in Pediatric Pulmonary Hypertension: An Investigative Approach Read More »

Embolization treatment of right pulmonary artery agenisis with patent ductus arteriosus causing pulmonary hypertension and hemoptysis: a case report and literature review

Fan Wei, Chang Yaowen, Wang WenhuiFirst Clinical Medical College of Lanzhou University and First Hospital of Lanzhou University.China Journal of Cardiothoracic SurgeryJ Cardiothorac Surg 2024; 19: DOI: 10.1186/s13019-024-02883-9 AbstractAs the pediatric patient with right pulmonary artery agenesis (PAA) matured, she progressively presented symptoms of pulmonary hypertension and hemoptysis. There is limited clinical literature on this condition,

Embolization treatment of right pulmonary artery agenisis with patent ductus arteriosus causing pulmonary hypertension and hemoptysis: a case report and literature review Read More »

Scroll to Top